Business
Baird Medical to Participate in the AAES 2025 Annual Meeting
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES), taking place May 17-19, 2025, at the Baird Center in Milwaukee, Wisconsin.
About this update from Baird Medical Investment Holdings Ltd
[{"type":"text","content":"NEW YORK, May 6, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES), taking place May 17-19, 2025, at the Baird Center in Milwaukee, Wisconsin.","length":428,"tagName":"p"},{"type":"image","alt":"Photo courtesy of AAES","displaySize":"","headline":null,"caption":"Photo courtesy of AAES","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":267,"url":"https://media.zenfs.com/en/prnewswire.com/993cab208a126d5d6e5c0644a9c59935"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/G1mjeOBbjhSpm7XSGGIAfA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ3MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/993cab208a126d5d6e5c0644a9c59935","width":400,"height":267}},"href":"https://mma.prnewswire.com/media/2679227/BDMD.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The AAES Annual Meeting is widely regarded as the premier gathering of endocrine surgeons in North America, convening leading experts, clinicians, researchers, and trainees in the field. The conference is dedicated to advancing the science and practice of endocrine surgery through the presentation of cutting-edge research, expert panels, and collaborative discussions focused on thyroid diseases, parathyroid, adrenal glands, and endocrine pancreas.","length":451,"tagName":"p"},{"type":"text","content":"Baird Medical's presence at the AAES 2025 meeting highlights the growing significance of its MWA technology in the evolving landscape of minimally invasive treatment options for endocrine conditions, particularly thyroid nodules. The participation provides an excellent opportunity for the Company to engage with key opinion leaders in endocrine surgery, share clinical updates on its MWA systems, and contribute to discussions on innovative patient care strategies.","length":470,"tagName":"p"},{"type":"text","content":"The Company views the AAES Annual Meeting as a crucial opportunity to gain firsthand insights into cutting-edge surgical advancements and evolving clinical trends in endocrine care. This engagement supports Baird Medical's strategic in...